Angelini Pharma
PrivateLast Round
Debt
4/14/2022
Total Funding Raised
$1.1B
Momentum Score
25 /100
Company Overview
Angelini Pharma is the pharmaceutical division of the Italian industrial group Angelini Industries. Founded in 1919, the company researches, develops, and commercializes health solutions with a primary focus on Brain Health (including mental health and epilepsy), Specialty & Primary Care, and Consumer Healthcare. It operates directly in over 20 countries, employing around 3,000 people, and its products are marketed in over 70 countries. The company has a history of developing its own molecules, such as trazodone and benzydamine, and also grows through strategic acquisitions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Angelini Pharma Comps
Public and private peers based on sector, stage, and business model.
Angelini Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | 4/14/2022 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Radiprodil identified as key asset in GRIN-NDD therapeutic area.
- Jan 22, 2026
Sergio Marullo di Condojanni named new Chief Executive Officer.
Angelini Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Angelini Pharma's valuation, stock price, and market status.
